Study guide
7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains
Registered Cardiac Electrophysiology Specialist RCES
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pre-Procedural Assessment & Patient Preparation
1.1 Procedure Room Preparation, Equipment Verification & Aseptic Readiness 1.2 Pre-Procedural Clinical Evaluation, Labs, Consents & The Universal Time-Out 1.3 Patient Identification, Transport, HIPAA & Procedural Documentation 1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation 1.5 Vascular Access Planning, Skin Preparation & Sterile Draping
2 Chapter 2: Cardiac Anatomy, Conduction & Electrophysiologic Foundations
2.1 Cardiac Anatomy for the EP Lab: Chambers, Access Routes & Coronary Supply 2.2 The Cardiac Conduction System, Action Potentials & Ion Channel Physiology 2.3 Cardiac Vector Analysis, 12-Lead ECG Fundamentals & Axis Determination
3 Chapter 3: EP Lab Instrumentation, Connectology & Lab Safety
3.1 EP Recording System Architecture, Signal Amplification & Frequency Filters 3.2 Cardiac Stimulator Operation, Junction Box Routing & Noise Troubleshooting 3.3 Electrical Safety, Electrical Units, Electrocautery & Fire Safety 3.4 Radiation Safety Physics, ALARA Principles, Shielding & Dose Limits 3.5 Procedural Supplies, Catheter Inventory, Surgical Instrumentation & Wound Closure
4 Chapter 4: Intra-Procedural Imaging, Sedation & Physiologic Monitoring
4.1 Fluoroscopic Projections (RAO, LAO, AP) & X-ray Tube Optimization 4.2 Intracardiac Echocardiography (ICE) Principles, Views & Catheter Navigation 4.3 Non-Radiographic Imaging: Cardiac CT/MRI, Image Fusion & Ultrasound-Guided Access 4.4 Conscious Sedation Protocols, Airway Management & Hemodynamic Monitoring 4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring
5 Chapter 5: EP Pharmacology, Anticoagulation & Emergency Drugs
5.1 Vaughan Williams Antiarrhythmic Classification & EP Electrophysiology 5.2 Diagnostic & Provocative Drugs: Adenosine, Isoproterenol, Epinephrine, Atropine 5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring 5.4 Heparin Protocol, ACT Monitoring & Emergency Reversal with Protamine 5.5 Oral Anticoagulants, Antiplatelets & Peri-Procedural Management 5.6 ACLS Algorithms & Emergency Medications in the EP Lab
6 Chapter 6: Catheter Navigation, Normal Electrograms & Baseline Intervals
6.1 Standard Diagnostic Catheter Positions & Fluoroscopic/Anatomical Landmarks 6.2 Intracardiac Electrogram Interpretation & Normal Baseline Intervals (PA, AH, HV) 6.3 His Bundle Electrogram Recording, Split His Potentials & Infranodal Conduction
7 Chapter 7: Programmed Electrical Stimulation & Refractory Periods
7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains 7.2 Refractory Period Determination (ERP, RRP, FRP) & Sinus Node Function Testing (SNRT, cSNRT) 7.3 AV Nodal Decremental Conduction & Dual AV Nodal Physiology
8 Chapter 8: Diagnostic Evaluation of Supraventricular & Ventricular Tachycardias
8.1 Narrow-Complex Tachycardias: Differential Diagnosis of AVNRT, AVRT & AT 8.2 Diagnostic Pacing Maneuvers: Entrainment, PPI-TCL, V-A-V vs V-A-A-V & His-Refractory PVCs 8.3 Wide-Complex Tachycardias & Ventricular Arrhythmia Mapping Criteria
9 Chapter 9: Bradyarrhythmias, AV Block & Atrial Arrhythmia Recognition
9.1 Bradyarrhythmias, AV Block Classification & Conduction System Disease 9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk
10 Chapter 10: 3D Electroanatomic Mapping & Ablation Biophysics
10.1 3D Electroanatomic Mapping Systems (Carto, EnSite, Rhythmia) Setup & Troubleshooting 10.2 Activation, Propagation & Bipolar Voltage Substrate Mapping 10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)
11 Chapter 11: Transseptal Access, Catheter Ablation Targets & Endpoints
11.1 Transseptal Puncture: Anatomy, Technique, Imaging Guidance & Complications 11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW) 11.3 Cavotricuspid Isthmus (CTI) Ablation for Typical Atrial Flutter 11.4 Pulmonary Vein Isolation (PVI) for AFib & Ventricular Tachycardia Ablation
12 Chapter 12: Cardiac Implantable Electronic Devices: Implantation & Testing
12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety 12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT 12.3 Cardiac Resynchronization Therapy (CRT) & Conduction System Pacing (HBP, LBBAP)
13 Chapter 13: CIED Interrogation, Programming & Troubleshooting
13.1 NBG Pacemaker Codes, Pacing Modes & Timing Cycles 13.2 CIED Interrogation Workflow, Programmer Operation & Peri-Procedural Reprogramming 13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes 13.4 Pacing & Sensing Malfunctions, Electromagnetic Interference & Temporary Pacing
14 Chapter 14: Specialized Devices, Extraction & Acute Procedural Emergencies
14.1 Subcutaneous ICD (S-ICD), Leadless Pacemakers & Left Atrial Appendage Closure 14.2 Transvenous Lead Extraction Tools, Techniques & Safety Precautions 14.3 Acute Procedural Emergencies: Perforation, Tamponade, Pericardiocentesis & Air Embolism
15 Chapter 15: Post-Procedural Care, Hemostasis & Complication Management
15.1 Femoral Hemostasis Techniques: Manual Compression, Figure-of-8 & Closure Devices 15.2 Post-Procedural Complications: Vascular Injury, AV Block, Esophageal Injury & Neurologic Deficits 15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care 15.4 Post-Procedure Patient Recovery, Discharge Education & Clinical Handover
7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains
Key Takeaways Explain This Topic AI
The strength-duration curve defines the non-linear hyperbolic relationship between electrical stimulus amplitude and pulse duration; rheobase is the minimal current required to achieve capture at infinite pulse duration, while chronaxie represents the pulse width at twice rheobase (0.4 to 0.8 ms in human myocardium).
Diastolic pacing threshold testing is performed at a fixed pulse width (typically 1.0 to 2.0 ms in diagnostic EP) while stepping down current output in milliamperes (mA) until loss of capture is observed.
Clinical safety margins mandate programming diagnostic pacing outputs at 2 to 3 times the diastolic current threshold (typically 1.5 to 5.0 mA) to prevent intermittent capture loss without causing excessive pacing polarization artifact or extracardiac stimulation.
A basal S1-S1 drive train standardly delivers 8 consecutive pacing stimuli at fixed Basal Cycle Lengths (600, 500, or 400 ms) to override sinus node automaticity, standardize action potential duration, and establish reproducible refractoriness prior to extrastimulus introduction.
Burst pacing delivers asynchronous rapid stimuli at a fixed short cycle length (e.g., 200 to 300 ms) to trigger reentrant circuits or achieve antitachycardia pacing termination, whereas incremental ramp pacing shortens successive cycle lengths to assess decremental AV conduction and Wenckebach points.
Last updated: September 2026
7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains
Programmed electrical stimulation (PES) is the core active diagnostic modality in the clinical cardiac electrophysiology laboratory. By delivering microsecond-to-millisecond electrical impulses directly to the endocardium, the electrophysiologist and EP specialist can systematically stress cardiac conduction pathways, characterize refractory periods, unmask dual pathway physiology, and induce or terminate clinical tachyarrhythmias. Executing these protocols safely and accurately requires an in-depth mastery of cellular stimulation biophysics, strength-duration curve mechanics, pacing threshold testing protocols, and pacing drive train architecture.
Biophysics of Cardiac Electrical Stimulation
Myocardial excitation begins at the cellular membrane. In non-pacemaker cardiac tissue (atrial myocardium, His-Purkinje system, and ventricular myocardium), the resting transmembrane potential ( V m V_m V m ) is maintained at approximately − 80 to − 90 mV -80\text{ to }-90\text{ mV} − 80 to − 90 mV through active transport pumps and background inward-rectifier potassium currents ( I K 1 I_{K1} I K 1 ). To initiate an all-or-none action potential, an external electrical stimulus must deliver sufficient charge to depolarize the transmembrane potential across a critical threshold potential ( V t h ≈ − 65 to − 60 mV V_{th} \approx -65\text{ to }-60\text{ mV} V t h ≈ − 65 to − 60 mV ).
When the threshold potential is reached, voltage-gated fast sodium channels ( N a V 1.5 Na_V1.5 N a V 1.5 ) undergo rapid conformational opening, generating a massive inward sodium current ( I N a I_{Na} I N a ) that drives the Phase 0 upstroke ( d V / d t m a x > 200 V/s dV/dt_{max} > 200\text{ V/s} d V / d t ma x > 200 V/s ). If the applied stimulus fails to elevate V m V_m V m to this threshold, only a sub-threshold local graded response occurs, and no propagating action potential is produced.
The Strength-Duration Curve
The quantity of electrical energy required to excite cardiac tissue is not constant; it depends on the dynamic relationship between stimulus amplitude (current in milliamperes, m A mA m A , or voltage in volts, V V V ) and stimulus duration (pulse width in milliseconds, m s ms m s ). This hyperbolic relationship is known as the strength-duration curve , mathematically described by the Weiss-Lapicque equation : I t h = I r h × ( 1 + c t ) I_{th} = I_{rh} \times \left(1 + \frac{c}{t}\right) I t h = I r h × ( 1 + t c )
Where:
- I t h I_{th} I t h = Threshold current required for myocardial capture at pulse duration t t t
- I r h I_{rh} I r h = Rheobase current
- c c c = Chronaxie pulse width
- t t t = Stimulus pulse width (duration) Current (mA)
- ^
- | Strength-Duration Curve
- | *
- | *
- 2x|----*----------------------- (2 x Rheobase)
- | *
- | *
- | *
- 1x|----------*----------------- Rheobase (Asymptote)
- | * * * * * * * *
- 0----+--------+-------------> Pulse Width (ms)
- 0 Chronaxie
- Key Biophysical Parameters
Rheobase : The absolute minimum electrical current (or voltage) required to stimulate the myocardium when the stimulus is delivered at an infinitely long pulse width ( t → ∞ t \to \infty t → ∞ ). In human cardiac tissue, typical diastolic rheobase current ranges from 0.2 to 0.8 mA . Delivering a current below the rheobase will never capture the tissue, regardless of how long the pulse duration is extended.
Chronaxie : The specific pulse width corresponding to an electrical threshold current that is exactly twice the rheobase ( 2 × I r h 2 \times I_{rh} 2 × I r h ). In human atrial and ventricular myocardium, the chronaxie typically ranges from 0.4 to 0.8 ms (averaging ~0.5 ms). Chronaxie represents the biophysical point of maximum energy efficiency . According to the formula for electrical energy delivered to a resistive load ( E = I 2 × R × t E = I^2 \times R \times t E = I 2 × R × t ), setting the pulse width significantly below the chronaxie requires disproportionately higher currents to capture, increasing energy drain and amplifier noise. Conversely, setting the pulse width far above the chronaxie wastes electrical energy along the flat asymptotic tail of the curve without achieving any meaningful reduction in threshold current.
Pulse Width Selection in Diagnostic EP vs. Permanent Pacemakers
Permanent Pacemakers & ICDs : Programmed pulse width is optimized for battery longevity, typically set between 0.4 ms and 0.5 ms (approximating the myocardial chronaxie). This balances energy conservation with an adequate voltage safety margin.
Diagnostic EP Lab Stimulators : Pulse width is routinely standardized at 1.0 ms or 2.0 ms (typically 1.0 ms in North American protocols, 2.0 ms in some European protocols). In the diagnostic EP suite, battery depletion is not a concern because stimulators operate on isolated AC line power. Setting the pulse width to 1.0 or 2.0 ms places stimulation on the flat, stable plateau of the strength-duration curve. At this plateau, minor fluctuations in catheter-tissue contact impedance caused by cardiac contraction or respiratory excursions produce negligible shifts in current threshold, ensuring consistent, reproducible diagnostic pacing throughout the study.
Diastolic Pacing Threshold Determination & Safety Margins
Accurate threshold testing is mandatory before performing diagnostic pacing protocols. Pacing at excessive outputs causes massive electrical artifacts and risk of far-field capture, while pacing at sub-threshold outputs leads to intermittent capture loss that can be misdiagnosed as physiological conduction block.
Diastolic Pacing Threshold Step-Down Protocol
The diastolic capture threshold is defined as the minimal electrical output (measured in milliamperes, m A mA m A ) required to consistently capture cardiac myocardium during late electrical diastole (Phase 4), outside all relative and absolute refractory periods.
Clinical Step-Down Protocol
Position the multipolar catheter securely against the target endocardium (e.g., High Right Atrium [HRA], Coronary Sinus [CS], or Right Ventricular Apex [RVA]).
Configure the stimulator pulse width to 1.0 ms (or 2.0 ms) and select a pacing cycle length slightly faster than the intrinsic heart rate (e.g., Basal Cycle Length [BCL] of 600 ms for an intrinsic rate of 70 bpm).
Initiate pacing at a known supra-threshold output, typically 5.0 mA .
Observe 1:1 capture on surface ECG leads and intracardiac channels, confirming that each pacing spike is immediately followed by a corresponding local depolarization (atrial electrogram and P wave, or ventricular electrogram and wide QRS complex).
Step down the current output progressively:
Decrease by 0.5 mA decrements from 5.0 mA down to 2.0 mA.
Decrease by 0.1 mA decrements below 2.0 mA until loss of capture is observed.
The last current output that produces consistent, 100% myocardial capture represents the diastolic pacing threshold .
Typical normal diastolic thresholds in acute, non-scarred tissue range between 0.3 mA and 1.0 mA at a 1.0-ms pulse width (with circuit impedance between 400 and 1,200 Ω \Omega Ω ).
Pacing Output Safety Margin in Diagnostic EP
Once the diastolic threshold is documented, the diagnostic pacing output must be programmed to provide an adequate safety margin :
Standard Diagnostic Safety Margin : Set at twice to three times diastolic threshold ( 2 × to 3 × threshold 2\times\text{ to }3\times\text{ threshold} 2 × to 3 × threshold ), or standardly programmed between 1.5 mA and 5.0 mA (typically 2.0 to 3.0 mA for atrial and ventricular pacing). Programmed Output (mA) = 2 × Diastolic Threshold (mA) \text{Programmed Output (mA)} = 2 \times \text{Diastolic Threshold (mA)} Programmed Output (mA) = 2 × Diastolic Threshold (mA)
Clinical Rationale for Safety Margin Standards :
Preventing Intermittent Capture Loss : During catheter manipulation, patient respiration, or sinus acceleration, catheter-tissue contact fluctuates. Pacing at twice threshold guarantees continuous capture without intermittent dropouts.
Avoiding Excessive Pacing Polarization Artifact : Pacing at high outputs (>10 to 20 mA) deposits substantial electrical charge across the electrode-tissue electrochemical double layer, generating prolonged polarization decay tails that blind the recording pre-amplifier and obscure sharp intrinsic His potentials or early local activation spikes.
Preventing Extracardiac & Far-Field Capture : Excessive atrial pacing output (e.g., >10 mA in the lateral right atrium) can directly capture the right phrenic nerve, causing diaphragmatic twitching. In the distal coronary sinus, excessive output can stimulate the left phrenic nerve or directly capture left ventricular myocardium across the atrioventricular groove, producing false diagnostic intervals.
Pacing Drive Trains and Stimulation Protocols
Diagnostic programmed electrical stimulation utilizes standardized stimulation sequences engineered to normalize electrophysiological conditions and interrogate specific conduction tissue.
1. The S 1 − S 1 S_1-S_1 S 1 − S 1 Basal Drive Train
The fundamental building block of programmed stimulation is the S 1 S_1 S 1 drive train (also called basal pacing). The stimulator delivers a series of consecutive pacing pulses at a fixed, regular Basal Cycle Length (BCL) . S1 S1 S1 S1 S1 S1 S1 S1 S2
- |<--BCL---->|<--BCL---->|<--BCL---->|<--BCL---->|<--BCL---->|<--BCL---->|<--BCL---->|<--BCL---->|<--CI--->|
- (1) (2) (3) (4) (5) (6) (7) (8) Premature
- Biophysical Purpose of the 8-Beat Drive Train
Standard diagnostic EP protocols utilize an 8-beat drive train ( 8 × S 1 8 \times S_1 8 × S 1 ). Delivering exactly 8 beats serves essential physiological functions:
Overriding Intrinsic Automaticity : Suppresses the sinus node pacemaker P-cells and eliminates spontaneous heart rate variability.
Erasing Electrical Restitution Memory : Cardiac action potential duration (APD) exhibits restitution properties; the duration of an action potential depends heavily on the preceding diastolic intervals. Delivering 8 continuous, fixed-interval beats overrides prior cycle length history and establishes a constant, steady-state action potential duration and repolarization plateau across the myocardium.
Standardizing Refractoriness : Because tissue refractory periods are strictly rate-dependent, introducing premature extrastimuli without a prior fixed drive train produces erratic, non-reproducible refractory measurements. An 8-beat train guarantees that each premature extrastimulus tests tissue conditioned by an identical electrophysiological baseline.
Standard Basal Cycle Lengths (BCL)
Clinical EP protocols test conduction and refractoriness at multiple standardized drive cycle lengths:
600 ms (100 bpm) : Standard initial diagnostic resting drive.
500 ms (120 bpm) : Moderate pacing rate used to unmask rate-dependent conduction abnormalities and dual pathways.
400 ms (150 bpm) : Rapid physiological drive used to challenge the AV node, evaluate His-Purkinje refractoriness, and test ventricular tachycardia inducibility.
Between each 8-beat drive train, a pause of 2 to 4 seconds is maintained to permit transient tissue recovery, prevent progressive pacing-induced ischemia, and avoid sustained autonomic reflex shifts.
2. Extrastimuli Hierarchy: Single ( S 2 S_2 S 2 ), Double ( S 3 S_3 S 3 ), and Triple ( S 4 S_4 S 4 )
Premature impulses delivered after a stable drive train are designated as extrastimuli :
Single Extrastimulus ( S 2 S_2 S 2 ) Protocol :
Introduced immediately following the 8th S 1 S_1 S 1 beat of the drive train.
The timing between the 8th S 1 S_1 S 1 and S 2 S_2 S 2 is termed the coupling interval (CI) , designated as S 1 − S 2 S_1-S_2 S 1 − S 2 .
Protocol: The S 1 − S 2 S_1-S_2 S 1 − S 2 interval is initialized in late diastole, typically at 400 ms or 500 ms (well outside the refractory period). With each successive 8-beat drive train, the S 1 − S 2 S_1-S_2 S 1 − S 2 coupling interval is decremented progressively by 10 ms or 20 ms (e.g., 400 ms → \to → 390 ms → \to → 380 ms ... down to tissue refractoriness).
Primary diagnostic objectives: Determines the Effective Refractory Period (ERP) of the atrium, AV node, or ventricle; unmasks dual AV nodal pathway physiology (producing an AH jump).
Double Extrastimuli ( S 3 S_3 S 3 ) Protocol :
Used when single extrastimuli fail to induce tachycardia or when assessing deep nodal and ventricular refractoriness.
Execution: The S 1 − S 2 S_1-S_2 S 1 − S 2 interval is fixed at a stable coupling interval, standardly set at 20 ms to 30 ms above the S 2 S_2 S 2 ERP . A second premature stimulus ( S 3 S_3 S 3 ) is introduced following S 2 S_2 S 2 .
The S 2 − S 3 S_2-S_3 S 2 − S 3 coupling interval is then decremented in 10-ms steps until S 3 S_3 S 3 reaches tissue refractoriness.
Primary diagnostic objectives: Inducing typical AVNRT, unmasking concealed bypass tracts, and triggering polymorphic or monomorphic ventricular tachycardia.
Triple Extrastimuli ( S 4 S_4 S 4 ) Protocol :
Utilized primarily in ischemic ventricular stimulation studies (VT stimulation protocol).
S 1 − S 2 S_1-S_2 S 1 − S 2 and S 2 − S 3 S_2-S_3 S 2 − S 3 are held fixed at their established supra-refractory intervals, and a third premature impulse ( S 4 S_4 S 4 ) is introduced and decremented in 10-ms steps down to ventricular refractoriness or a protocol safety floor (e.g., 200 ms).
3. Burst Pacing vs. Incremental Ramp Pacing
When programmed extrastimuli fail to elicit target arrhythmias, continuous rapid pacing protocols are engaged:
Feature Burst Pacing Incremental Ramp Pacing
Pacing Architecture Fixed, rapid cycle length throughout the train Stepwise accelerating train (cycle length progressively shortens)
Typical Protocol 8 to 15 beats at a fixed rate (e.g., 250 ms = 240 bpm) Pacing starts at 600 ms; decrements by 10 ms every beat or 2-3 sec
Electrophysiological Target Abruptly fragments conduction across non-uniform refractory tissue Progressively stresses decremental conduction properties
Primary Diagnostic Use Inducing atrial fibrillation, atrial flutter, or AVNRT Determining AV nodal Wenckebach point; measuring SNRT
Therapeutic Application Antitachycardia Pacing (ATP) to terminate reentrant VT/SVT Gradual pacing overdrive to suppress ectopic automaticity
Risk Profile High likelihood of triggering non-clinical AF or VF Controlled, predictable development of physiological heart block
Burst Pacing Mechanics : A train of rapid stimuli (typically 5 to 20 beats) delivered at a fixed, very short cycle length (e.g., 300 ms down to 200 ms). Because the stimuli arrive asynchronously and abruptly during relative refractory periods, wavefront conduction breaks apart across regional conduction barriers, producing wavebreaks and initiating functional reentry.
Incremental Ramp Pacing Mechanics : Continuous pacing begins at a cycle length slightly faster than baseline sinus rhythm and accelerates in a controlled manner. As the cycle length shortens, the EP specialist observes the electrograms for the appearance of decremental conduction, bundle branch aberrancy, and ultimately the onset of AV nodal Wenckebach block (the cycle length at which Mobitz I second-degree AV block occurs).